Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
J
322510
vs
K
KOSPI 200
Over the past 12 months, JLK Inc has underperformed KOSPI 200, delivering a return of -10% compared to KOSPI 200's +119% growth.
Stocks Performance
322510 vs KOSPI 200
Performance Gap
322510 vs KOSPI 200
Performance By Year
322510 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
JLK Inc
Glance View
JLK Inc is a South Korean medical software company that makes artificial intelligence tools for reading medical images. Its products help doctors look at CT and MRI scans, especially in emergency care such as stroke detection, brain imaging, and related neurological conditions. The company sells software that can flag abnormal findings, support faster decisions, and help hospitals handle scans more efficiently. Its main customers are hospitals, clinics, and healthcare providers that use imaging equipment and need faster specialist support. JLK makes money by selling AI software and related service contracts to medical institutions and by licensing its diagnostic programs for use in clinical workflows. In practice, it sits between the imaging scan and the doctor’s final diagnosis, acting as a decision-support layer rather than a device maker. What makes JLK’s business different is that it focuses on narrow, high-value clinical tasks where speed matters and where software can improve how doctors triage patients. Instead of selling general-purpose hospital software, it builds image-analysis tools for specific medical use cases. That gives the company a role in the healthcare technology chain as a specialist AI layer for diagnostic imaging.